Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37


Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.

Zhang Q, Duplany A, Moncollin V, Mouradian S, Goillot E, Mazelin L, Gauthier K, Streichenberger N, Angleraux C, Chen J, Ding S, Schaeffer L, Gangloff YG.

J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):35-53. doi: 10.1002/jcsm.12336. Epub 2018 Nov 21.


PAK1 and CtBP1 Regulate the Coupling of Neuronal Activity to Muscle Chromatin and Gene Expression.

Thomas JL, Moncollin V, Ravel-Chapuis A, Valente C, Corda D, Méjat A, Schaeffer L.

Mol Cell Biol. 2015 Dec;35(24):4110-20. doi: 10.1128/MCB.00354-15. Epub 2015 Sep 28.


Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy.

Ratti F, Ramond F, Moncollin V, Simonet T, Milan G, Méjat A, Thomas JL, Streichenberger N, Gilquin B, Matthias P, Khochbin S, Sandri M, Schaeffer L.

J Biol Chem. 2015 Feb 13;290(7):4215-24. doi: 10.1074/jbc.M114.600916. Epub 2014 Dec 15.


Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.

Macaire H, Riquet A, Moncollin V, Biémont-Trescol MC, Duc Dodon M, Hermine O, Debaud AL, Mahieux R, Mesnard JM, Pierre M, Gazzolo L, Bonnefoy N, Valentin H.

J Biol Chem. 2012 Jun 15;287(25):21357-70. doi: 10.1074/jbc.M112.340992. Epub 2012 May 2.


Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.

Risson V, Mazelin L, Roceri M, Sanchez H, Moncollin V, Corneloup C, Richard-Bulteau H, Vignaud A, Baas D, Defour A, Freyssenet D, Tanti JF, Le-Marchand-Brustel Y, Ferrier B, Conjard-Duplany A, Romanino K, Bauché S, Hantaï D, Mueller M, Kozma SC, Thomas G, Rüegg MA, Ferry A, Pende M, Bigard X, Koulmann N, Schaeffer L, Gangloff YG.

J Cell Biol. 2009 Dec 14;187(6):859-74. doi: 10.1083/jcb.200903131.


Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.

Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, Kobari L, Thierry D, Douay L.

Nat Biotechnol. 2002 May;20(5):467-72.


Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets.

Kaiser P, Moncollin V, Clarke DJ, Watson MH, Bertolaet BL, Reed SI, Bailly E.

Genes Dev. 1999 May 1;13(9):1190-202.


Molecular cloning of a rat 49-kDa TBP-interacting protein (TIP49) that is highly homologous to the bacterial RuvB.

Kanemaki M, Makino Y, Yoshida T, Kishimoto T, Koga A, Yamamoto K, Yamamoto M, Moncollin V, Egly JM, Muramatsu M, Tamura T.

Biochem Biophys Res Commun. 1997 Jun 9;235(1):64-8.


A 3' --> 5' XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription.

Hwang JR, Moncollin V, Vermeulen W, Seroz T, van Vuuren H, Hoeijmakers JH, Egly JM.

J Biol Chem. 1996 Jul 5;271(27):15898-904.


MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH.

Adamczewski JP, Rossignol M, Tassan JP, Nigg EA, Moncollin V, Egly JM.

EMBO J. 1996 Apr 15;15(8):1877-84.


Structures of the rat proteasomal ATPases: determination of highly conserved structural motifs and rules for their spacing.

Makino Y, Yogosawa S, Kanemaki M, Yoshida T, Yamano K, Kishimoto T, Moncollin V, Egly JM, Muramatsu M, Tamura T.

Biochem Biophys Res Commun. 1996 Mar 27;220(3):1049-54.


Genomic structure of the human TATA-box-binding protein (TBP).

Chalut C, Gallois Y, Poterszman A, Moncollin V, Egly JM.

Gene. 1995 Aug 19;161(2):277-82.


Partial characterization of the DNA repair protein complex, containing the ERCC1, ERCC4, ERCC11 and XPF correcting activities.

van Vuuren AJ, Appeldoorn E, Odijk H, Humbert S, Moncollin V, Eker AP, Jaspers NG, Egly JM, Hoeijmakers JH.

Mutat Res. 1995 Jul;337(1):25-39.


p53 modulation of TFIIH-associated nucleotide excision repair activity.

Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Freidberg EC, Evans MK, Taffe BG, et al.

Nat Genet. 1995 Jun;10(2):188-95.


Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.

Bellorini M, Moncollin V, D'Incalci M, Mongelli N, Mantovani R.

Nucleic Acids Res. 1995 May 25;23(10):1657-63.


TFIIH: a link between transcription, DNA repair and cell cycle regulation.

Seroz T, Hwang JR, Moncollin V, Egly JM.

Curr Opin Genet Dev. 1995 Apr;5(2):217-21. Review.


Mammalian DNA nucleotide excision repair reconstituted with purified protein components.

Aboussekhra A, Biggerstaff M, Shivji MK, Vilpo JA, Moncollin V, Podust VN, Protić M, Hübscher U, Egly JM, Wood RD.

Cell. 1995 Mar 24;80(6):859-68.


Transcription by RNA polymerase II: a process linked to DNA repair.

Chalut C, Moncollin V, Egly JM.

Bioessays. 1994 Sep;16(9):651-5. Review.


p44 and p34 subunits of the BTF2/TFIIH transcription factor have homologies with SSL1, a yeast protein involved in DNA repair.

Humbert S, van Vuuren H, Lutz Y, Hoeijmakers JH, Egly JM, Moncollin V.

EMBO J. 1994 May 15;13(10):2393-8.


The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor.

Schaeffer L, Moncollin V, Roy R, Staub A, Mezzina M, Sarasin A, Weeda G, Hoeijmakers JH, Egly JM.

EMBO J. 1994 May 15;13(10):2388-92.


Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.

Caron C, Rousset R, Béraud C, Moncollin V, Egly JM, Jalinot P.

EMBO J. 1993 Nov;12(11):4269-78.


The major histocompatibility complex (MHC) Ea promoter: sequences and factors at the initiation site.

Mantovani R, Tora L, Moncollin V, Egly JM, Benoist C, Mathis D.

Nucleic Acids Res. 1993 Oct 25;21(21):4873-8.


Common and unique transcription factor requirements of human U1 and U6 snRNA genes.

Bernués J, Simmen KA, Lewis JD, Gunderson SI, Polycarpou-Schwarz M, Moncollin V, Egly JM, Mattaj IW.

EMBO J. 1993 Sep;12(9):3573-85.


DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor.

Schaeffer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH, Chambon P, Egly JM.

Science. 1993 Apr 2;260(5104):58-63.


Expression in Escherichia coli: purification and properties of the recombinant human general transcription factor rTFIIB.

Moncollin V, Schaeffer L, Chalut C, Egly JM.

Protein Expr Purif. 1992 Oct;3(5):374-9.


The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes.

White J, Brou C, Wu J, Lutz Y, Moncollin V, Chambon P.

EMBO J. 1992 Jun;11(6):2229-40.


Purification and interaction properties of the human RNA polymerase B(II) general transcription factor BTF2.

Gerard M, Fischer L, Moncollin V, Chipoulet JM, Chambon P, Egly JM.

J Biol Chem. 1991 Nov 5;266(31):20940-5.


Expression in Escherichia coli: purification and properties of the yeast general transcription factor TFIID.

Burton N, Cavallini B, Kanno M, Moncollin V, Egly JM.

Protein Expr Purif. 1991 Oct-Dec;2(5-6):432-41.


A general transcription factor forms a stable complex with RNA polymerase B (II).

Zheng XM, Moncollin V, Egly JM, Chambon P.

Cell. 1987 Jul 31;50(3):361-8.


Purification of a factor specific for the upstream element of the adenovirus-2 major late promoter.

Moncollin V, Miyamoto NG, Zheng XM, Egly JM.

EMBO J. 1986 Oct;5(10):2577-84.


Stimulation of in vitro transcription by the upstream element of the adenovirus-2 major late promoter involves a specific factor.

Miyamoto NG, Moncollin V, Wintzerith M, Hen R, Egly JM, Chambon P.

Nucleic Acids Res. 1984 Dec 11;12(23):8779-99.


Is actin a transcription initiation factor for RNA polymerase B?

Egly JM, Miyamoto NG, Moncollin V, Chambon P.

EMBO J. 1984 Oct;3(10):2363-71.

Supplemental Content

Loading ...
Support Center